SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Machaon who wrote (24562)8/16/1998 2:30:00 AM
From: Andrew H  Read Replies (1) of 32384
 
>>Andrew, Henry has been saying for a long time that LGND is way underfunded. The 2nd quarter earnings report really brings that home. They are going to have to come up with some creative financing.<<

Creative financing? I hope that does not mean more dilution. My biggest concern about LGND is that there are an awful lot of shares out there. I still have questions about the Seragen acquisition.

My feeling is that LGND needs to get its expenditures a bit more under control until it begins to get some product income. Yes, they have a great pipeline, but I think their current programs are more than sufficient to keep them busy.

LGND could eventually be a goldmine, but I think there is a ways to go. The first few indications will have small markets. I would like to see some more data for the larger indications, including the diabetes data. I agree the price is pretty cheap here, but I also think another 10M shares would be very damaging. I am watching closely.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext